Publications

Cell.com

Targeting Mitosis in Cancer: Emerging Strategies

Carmen Dominguez-Brauer, Kelsie L. Thu, Jacqueline M. Mason, Heiko Blaser, Mark R. Bray...

Nature.com

Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial

Zachary W. Veitch, David W. Cescon, Trisha Denny, Lisa-Maria Yonemoto, Graham Fletcher...

Cell.com

Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent

Jacqueline M. Mason, Dan Chi-Chia Lin, Xin Wie, Yi Che, Yi Yao….

Pnas.org

Functional Characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer

Jacqueline M. Mason, Xin Wei, Graham C. Fletcher, Reza Kiarash, Richard Brokx...